1. Home
  2. WVE vs UDMY Comparison

WVE vs UDMY Comparison

Compare WVE & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • UDMY
  • Stock Information
  • Founded
  • WVE 2012
  • UDMY 2009
  • Country
  • WVE Singapore
  • UDMY United States
  • Employees
  • WVE N/A
  • UDMY 1246
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • UDMY Other Consumer Services
  • Sector
  • WVE Health Care
  • UDMY Real Estate
  • Exchange
  • WVE Nasdaq
  • UDMY Nasdaq
  • Market Cap
  • WVE 915.6M
  • UDMY 1.1B
  • IPO Year
  • WVE 2015
  • UDMY 2021
  • Fundamental
  • Price
  • WVE $6.50
  • UDMY $7.05
  • Analyst Decision
  • WVE Strong Buy
  • UDMY Buy
  • Analyst Count
  • WVE 13
  • UDMY 11
  • Target Price
  • WVE $20.15
  • UDMY $10.10
  • AVG Volume (30 Days)
  • WVE 1.0M
  • UDMY 1.2M
  • Earning Date
  • WVE 08-07-2025
  • UDMY 07-30-2025
  • Dividend Yield
  • WVE N/A
  • UDMY N/A
  • EPS Growth
  • WVE N/A
  • UDMY N/A
  • EPS
  • WVE N/A
  • UDMY N/A
  • Revenue
  • WVE $104,939,000.00
  • UDMY $790,019,000.00
  • Revenue This Year
  • WVE N/A
  • UDMY $1.87
  • Revenue Next Year
  • WVE $1.94
  • UDMY $4.15
  • P/E Ratio
  • WVE N/A
  • UDMY N/A
  • Revenue Growth
  • WVE N/A
  • UDMY 5.43
  • 52 Week Low
  • WVE $4.87
  • UDMY $5.68
  • 52 Week High
  • WVE $16.74
  • UDMY $10.61
  • Technical
  • Relative Strength Index (RSI)
  • WVE 45.10
  • UDMY 50.02
  • Support Level
  • WVE $6.67
  • UDMY $6.76
  • Resistance Level
  • WVE $7.10
  • UDMY $7.21
  • Average True Range (ATR)
  • WVE 0.38
  • UDMY 0.21
  • MACD
  • WVE -0.02
  • UDMY -0.02
  • Stochastic Oscillator
  • WVE 7.77
  • UDMY 42.46

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

Share on Social Networks: